Filed: 10/17/2024ACC: 0002013737-24-000011
📋 What this filing means
SPEAR HOLDINGS RSC LTD filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $99.76M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$99.76M
Total AUM (reported)
275.83K
Total Shares
Allocation by class
N Y REGISTRY SHS$92.01M92.2%
NAMEN AKT$7.75M7.8%
Portfolio Concentration
Top 3$99.76M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 275.83K
Sole
Full voting authority
275.83K
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
ASML Holding NV
SOLEShares110.83K
TypeSH
Market value$92.01M
92.23%
Sole
110.83K
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares165K
TypeSH
Market value$7.75M
7.77%
Sole
165K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ASML Holding NVSOLE | N Y REGISTRY SHS | 110.83K | SH | $92.01M 92.23% | 110.83K | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 165K | SH | $7.75M 7.77% | 165K | 0.00 | 0.00 |